Akebia Therapeutics (AKBA) vs Anika Therapeutics (ANIK)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 9, 2026.
Summary
Anika Therapeutics (ANIK) has outperformed Akebia Therapeutics (AKBA) over the past year, gaining 108.1% versus a loss of 71.4%. Over five years, ANIK leads with a -53.8% price change compared with -71.4% for AKBA. Anika Therapeutics is the larger company by market cap ($257.4 million vs $225.8 million), about 1.1 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | AKBA | ANIK |
|---|---|---|
| Share price | $0.8148 | $19.23 |
| Market cap | $225.79M | $257.35M |
| 1-day change | -6.71% | -1.54% |
| YTD return | -49.39% | +100.10% |
| 1-year return | -71.41% | +108.12% |
| 5-year return | -71.41% | -53.84% |
| Forward P/E | — | 20.24 |
| EPS (TTM) | $-0.12 | $-0.23 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $3.20 | $22.88 |
| 52-week low | $0.814 | $8.67 |
| Distance from 52-week high | -74.54% | -15.95% |
| Analyst consensus | none | strong_buy |
| Avg. price target upside | +381.10% | +19.60% |
| Average volume | 6.18M | 98.57K |
| Shares outstanding | 277.11M | 13.38M |
| Employees | 194 | 235 |
| Sector | Health Care | Health Care |
| Industry | Biotechnology: Pharmaceutical Preparations | Medical/Dental Instruments |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- ANIK has outperformed AKBA by 179.5 percentage points over the past year.
About Akebia Therapeutics
AKBA stock →Akebia Therapeutics, Inc., a biopharmaceutical company, focuses on the development and commercialization of therapeutics for patients with kidney diseases. Its product portfolio includes Vafseo (vadadustat), an oral hypoxia-inducible factor prolyl hydroxylase, for the treatment of anemia due to chronic kidney disease (CKD) in dialysis-dependent (DD) and non-dialysis dependent (NDD) patients; and Auryxia, a ferric citrate that is used to control the serum phosphorus levels in adult patients with DD-CKD and the treatment of iron deficiency anemia in adult patients with NDD-CKD.
Health Care · Biotechnology: Pharmaceutical Preparations · 194 employees
About Anika Therapeutics
ANIK stock →Anika Therapeutics, Inc., a joint preservation company, focuses on early intervention orthopedics in the United States, Europe, and internationally. The company offers osteoarthritis (OA) pain management products and services, such as Monovisc and Orthovisc, which are single- and multi-injection, HA viscosupplement products indicated for pain relief from OA conditions, as well as Cingal, a non-opioid, single-injection OA pain management product; regenerative solutions, including an HA-based scaffold with bone and tendon fixation components and arthroscopic delivery instruments; Hyalofast, a resorbable scaffold used for single stage cartilage regeneration; and Tactoset injectable bone substitute, an HA-enhanced injectable bone repair therapy designed to treat insufficiency fractures and augment hardware fixation.
Health Care · Medical/Dental Instruments · 235 employees
AKBA vs ANIK FAQ
Which is bigger, Akebia Therapeutics or Anika Therapeutics?
Anika Therapeutics (ANIK) is larger, with a market capitalization of $257.35M compared with $225.79M for Akebia Therapeutics (AKBA).
Which stock has performed better over the past year, AKBA or ANIK?
ANIK returned +108.12% over the past 12 months, compared with -71.41% for AKBA (price return, excluding dividends). Past performance does not predict future results.
Are Akebia Therapeutics and Anika Therapeutics in the same industry?
Both are in the Health Care sector, but in different industries: Biotechnology: Pharmaceutical Preparations for Akebia Therapeutics and Medical/Dental Instruments for Anika Therapeutics.